Weight Loss, drugs like Wegovy

How Much Should Weight Loss Drugs Cost?
A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now.
Millions of people are taking compounded weight loss drugs. Now they're about to disappear.
Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now soon they may be unavailable to most.
The FDA Cracking Down on Compounded Weight Loss Drugs – Here’s What It Means for Telehealth Companies and Consumers
After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they will be prohibiting like-for-like compounded versions.
Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for weight loss, as is permissible by the FDA.
These discounted versions of popular weight-loss drugs are going away: What to know
Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their medications elsewhere.
FBI issues safety warning about counterfeit versions of weight loss drug semaglutide
Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is also approved to reduce the risk of major cardiovascular events in adults with obesity or who are overweight with established cardiovascular disease.
Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
This story mentions weight, weight loss, and/or GLP-1 drugs. In the last few years, GLP-1s, prescription weight loss medications for people who are obese or who are overweight and have one weight-related health condition,
Compound versions of weight loss drugs will no longer be available, FDA rules
Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available after a decision by the U.S. Food and Drug Administration. The agency has ordered compounding pharmacies to stop making compound versions of GLP-1 drugs now that the drugs are no longer in short supply.
Medications For Weight Loss
Dr. Alexandro Zarruk, MD, MSc., FACP, FRCPC, Internal Medicine, talks about medications that can help patients lose weight.
Son, 11, Finds Mom on the Floor 'Coughing Up Blood' After She Abused Unprescribed Weight-Loss Injectables
Gill Riley, who wasn't obese, regrets taking unprescribed weight-loss medication she purchased from a friend 'to be skinny' ...
FBI gives new warning about fake weight loss drugs being sold in Georgia
The federal agency’s new alert is about counterfeit drugs claiming to have semaglutide — the key ingredient in weight loss ...
The American Journal of Managed Care10h
Tirzepatide and Semaglutide Improve Weight Loss, Cardiovascular Conditions, but Deemed Too Expensive
Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...
My hair came out in clumps on a weight loss drug like Ozempic — 2 steps slowed the shedding
Desiree Rodriguez lost 35 pounds on a drug like Ozempic — but the tradeoff was losing “clumps” of her hair. She spoke to The Post about how she managed to minimize the hair loss.
First for Women on MSN10h
Jim Gaffigan on Losing 50 Lbs With Mounjaro: ‘Weight Loss Drugs Aren't Cheating'
Contrary to some celebrities who avoid disclosing whether they used medication to help them lose weight, Jim Gaffigan ...
Woman's World on MSN7h
Study: Postmenopausal Women Lose More Weight With GLP-1 and HRT
It seems demand is growing amongst women in perimenopause, menopause and postmenopause looking for multifaceted weight loss ...
'I'm a pharmacist - worrying rise in patients needing organ removed with weight loss jabs'
Deborah Grayson, a top pharmacist and nutritional therapist, has warned that weight loss medication can cause an inflamed ...
BenefitsPRO13h
The weight loss drug dilemma: How employers can overcome coverage gaps and take control
With health care costs rising and obesity-related conditions impacting workplace productivity, employers are increasingly ...